Folkehelse og offentlig tillit – Nordic Pharmas omdømme

Time: Thursday 26 June at 13:00–13:55

Tillit til legemiddelindustrien er avgjørende for folkehelsen – men tilliten er skjør. Hva driver tilliten i en sektor formet av høye forventninger og streng regulering? Og hva skjer når tilliten til den nordiske legemiddelindustrien begynner å svekke?

Join us live at Almedalen or via Teams. The event will take place on a historical sailing ship! You’ll find the schooner Svanhild af Borgå docked at Österdahls Brygga in the port of Visby. Please register for the seminar below and make sure you receive a confirmation email.

The pharmaceutical industry plays a crucial role in public health, yet trust in companies remains fragile. While innovation and life-saving treatments drive progress, concerns over pricing, transparency, and corporate ethics continue to shape public perception. What builds confidence in this highly regulated sector, and what erodes it?

Reputation and Trust Analytics presents findings from a comprehensive study on trust in pharmaceutical companies across the Nordics. The analysis highlights how reputation impacts on stakeholder behaviors. How can the industry balance innovation with accountability? What role do communication, policy, and corporate responsibility play in securing trust?

Deltakerne

Edvard Agrell, Corporate Public Affairs Manager, Bayer

Erik Kjellin, Head of Press, Lif – De Forskande Läkemedelsföretagen

Pia Steensland, Director of Policy & Public affairs, Pfizer Sverige

Tobias Lundin Gerdås, Policy and Government Affairs Partner, Roche Sweden

Sofia Rydgren Stale, President, Läkarförbundet

Andrei Sergejeff , seniorrådgiver, omdømme- og tillitsanalyse

Peter Markström , rådgiver, omdømme- og tillitsanalyse

Andrei Sergejeff, Senior Advisor, Reputation and Trust Analytics